Opendata, web and dolomites

BACRES

Feasibility study: Cloud-based diagnostic software for infectious diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BACRES project word cloud

Explore the words cloud of the BACRES project. It provides you a very rough idea of what is the project "BACRES" about.

connection    internet    intensive    routine    antibiotic    dna    first    threats    doctor    download    bn    launch    world    infections    48    takes    worth    human    market    feasibility    proprietary    society    automatically    healthcare    billion    ing    resource    bacteria    1928    marking    15    identification    decision    confer    give    treatment    12    demands    customers    software    version    time    contributor    ce    solution    longer    55    ineffective    recourse    complete    diagnostics    tests    million    direct    care    deaths    annually    raw    sequencing    modern    service    data    minutes    shortened    laboratory    sampling    platform    advantage    validation    hospital    diagnosis    computing    hours    slow    profiles    combines    transmission    2017    thing    mortality    diagnostic    ngs    resistance    patient    resistant    bacterial    clinical    excess    consuming    diminished    upload    cloud    generation    bioinformatics    health    organization    efficient    gt   

Project "BACRES" data sheet

The following table provides information about the project.

Coordinator
1928DIAGNOSTICS AB 

Organization address
address: STENA CENTER 1D
city: GOTEBORG
postcode: 412 92
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website http://www.1928diagnostics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    1928DIAGNOSTICS AB SE (GOTEBORG) coordinator 50˙000.00

Map

 Project objective

The problem of antibiotic resistance is considered one of the largest threats to human health by the World Health Organization (WHO). In EU and the US antibiotic resistance infections have been estimated to cause > 48 000 deaths from 2,5 million resistant infections and confer an excess direct healthcare cost of € 20 billion annually. A major contributor to this is current diagnostic methods, being slow (longer than 48 hours), resource-consuming and/or non comprehensive resulting in ineffective treatment. 1928 Diagnostics is developing a software solution that takes advantage of modern DNA technology (next generation sequencing, NGS) that is currently not used in clinical routine due to complex data analysis that is time and recourse intensive. Our solution is a software-as-a-service that combines cloud computing and a proprietary bioinformatics platform that automatically processes large and complex data to give resistance profiles as well as bacterial identification in just 15 minutes, enabling complete diagnosis in under 12 hours. The only thing required at the hospital laboratory is an internet connection in order to upload NGS raw data and to download the resistance profiles that will be used as a decision support for the doctor in the treatment selection for a particular patient. The result is shortened time from patient sampling to treatment, resulting in reduced mortality, less transmission of resistant bacteria and diminished costs for the health care system and society. Our product addresses a market that is worth over € 8 BN based on 55 million potential tests in EU and US. The feasibility study will focus on understanding the customers and market demands for the first version of the product in order to reach the market in the most efficient way. In a following Phase 2 project activities will include product development, clinical validation studies and CE marking activities to support product launch in 2017.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACRES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BACRES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

oWBI (2018)

Osmotic Wearable Bolus Injector (oWBI) for viscous drug delivery

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More